Design Therapeutics IncNASDAQ:DSGN
- LAST PRICE5.2500
- TODAY'S CHANGE (%)0.3500 (7.1429%)
- Bid / Lots5.1500/ 2
- Ask / Lots5.4200/ 3
- Open / Previous Close5.0000 / 4.9000
- Day Range
- 52 Week Range
- Volume229,885
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DSGN |
|---|---|---|
| 09:32 ET | 827 | 5 |
| 09:36 ET | 1600 | 4.99 |
| 09:38 ET | 6559 | 5.05 |
| 09:39 ET | 100 | 5.055 |
| 09:48 ET | 1100 | 5.03 |
| 09:50 ET | 230 | 5.05 |
| 09:52 ET | 1300 | 5.07 |
| 09:54 ET | 100 | 5.09 |
| 09:56 ET | 100 | 5.08 |
| 09:57 ET | 700 | 5.09 |
| 09:59 ET | 400 | 5.07 |
| 10:01 ET | 100 | 5.08 |
| 10:06 ET | 900 | 5.05 |
| 10:08 ET | 100 | 5.05 |
| 10:15 ET | 100 | 5.02 |
| 10:17 ET | 100 | 5 |
| 10:19 ET | 100 | 4.94 |
| 10:21 ET | 100 | 4.92 |
| 10:26 ET | 1967 | 4.95 |
| 10:28 ET | 100 | 4.97 |
| 10:32 ET | 1853 | 4.95 |
| 10:35 ET | 100 | 4.93 |
| 10:37 ET | 1100 | 4.98 |
| 10:48 ET | 1952 | 4.96 |
| 10:50 ET | 1322 | 4.98 |
| 10:51 ET | 100 | 4.97 |
| 10:55 ET | 1210 | 4.97 |
| 10:57 ET | 200 | 4.97 |
| 11:02 ET | 3429 | 4.965 |
| 11:04 ET | 1581 | 4.97 |
| 11:06 ET | 100 | 4.97 |
| 11:08 ET | 1193 | 4.97 |
| 11:09 ET | 2872 | 4.9881 |
| 11:11 ET | 200 | 4.99 |
| 11:13 ET | 902 | 5 |
| 11:15 ET | 100 | 5 |
| 11:18 ET | 430 | 5 |
| 11:24 ET | 199 | 4.9996 |
| 11:29 ET | 300 | 4.99 |
| 11:31 ET | 100 | 5 |
| 11:33 ET | 687 | 4.99 |
| 11:36 ET | 200 | 4.985 |
| 11:42 ET | 700 | 5 |
| 11:44 ET | 2689 | 5.05 |
| 11:45 ET | 987 | 5.04 |
| 11:47 ET | 596 | 5.025 |
| 11:49 ET | 600 | 5 |
| 11:51 ET | 700 | 5.05 |
| 11:56 ET | 1339 | 5.03 |
| 12:00 ET | 3733 | 5.08 |
| 12:03 ET | 10982 | 5.11 |
| 12:05 ET | 841 | 5.09 |
| 12:07 ET | 626 | 5.07 |
| 12:09 ET | 600 | 5.055 |
| 12:12 ET | 100 | 5.04 |
| 12:14 ET | 100 | 5.04 |
| 12:16 ET | 100 | 5.04 |
| 12:20 ET | 1100 | 5.06 |
| 12:21 ET | 300 | 5.06 |
| 12:23 ET | 100 | 5.06 |
| 12:27 ET | 1105 | 5.08 |
| 12:34 ET | 300 | 5.08 |
| 12:36 ET | 100 | 5.085 |
| 12:48 ET | 100 | 5.08 |
| 01:01 ET | 100 | 5.085 |
| 01:03 ET | 100 | 5.07 |
| 01:10 ET | 300 | 5.09 |
| 01:12 ET | 595 | 5.08 |
| 01:14 ET | 4937 | 5.13 |
| 01:15 ET | 4440 | 5.15 |
| 01:24 ET | 345 | 5.11 |
| 01:26 ET | 100 | 5.11 |
| 01:28 ET | 850 | 5.11 |
| 01:32 ET | 200 | 5.125 |
| 01:33 ET | 600 | 5.15 |
| 01:35 ET | 762 | 5.11 |
| 01:37 ET | 2000 | 5.1 |
| 01:42 ET | 100 | 5.11 |
| 01:46 ET | 508 | 5.14 |
| 01:48 ET | 100 | 5.125 |
| 01:51 ET | 994 | 5.14 |
| 01:55 ET | 100 | 5.12 |
| 01:57 ET | 100 | 5.12 |
| 02:02 ET | 100 | 5.11 |
| 02:04 ET | 300 | 5.13 |
| 02:06 ET | 5392 | 5.19 |
| 02:08 ET | 200 | 5.16 |
| 02:09 ET | 100 | 5.18 |
| 02:11 ET | 500 | 5.2099 |
| 02:13 ET | 1300 | 5.21 |
| 02:15 ET | 667 | 5.2 |
| 02:20 ET | 2490 | 5.2 |
| 02:22 ET | 700 | 5.21 |
| 02:24 ET | 1300 | 5.21 |
| 02:26 ET | 100 | 5.22 |
| 02:27 ET | 1300 | 5.1901 |
| 02:29 ET | 3767 | 5.2 |
| 02:31 ET | 4515 | 5.205 |
| 02:36 ET | 100 | 5.22 |
| 02:38 ET | 400 | 5.205 |
| 02:42 ET | 200 | 5.205 |
| 02:44 ET | 100 | 5.205 |
| 02:47 ET | 900 | 5.2 |
| 02:49 ET | 5500 | 5.2 |
| 02:51 ET | 200 | 5.21 |
| 02:54 ET | 3940 | 5.21 |
| 02:56 ET | 1001 | 5.23 |
| 02:58 ET | 2326 | 5.22 |
| 03:02 ET | 437 | 5.206 |
| 03:03 ET | 6049 | 5.25 |
| 03:05 ET | 900 | 5.2495 |
| 03:07 ET | 400 | 5.23 |
| 03:09 ET | 1652 | 5.25 |
| 03:12 ET | 100 | 5.26 |
| 03:14 ET | 337 | 5.26 |
| 03:18 ET | 2290 | 5.25 |
| 03:20 ET | 100 | 5.25 |
| 03:21 ET | 300 | 5.25 |
| 03:23 ET | 100 | 5.25 |
| 03:25 ET | 394 | 5.26 |
| 03:27 ET | 100 | 5.26 |
| 03:30 ET | 300 | 5.24 |
| 03:32 ET | 500 | 5.22 |
| 03:34 ET | 632 | 5.225 |
| 03:36 ET | 100 | 5.22 |
| 03:38 ET | 747 | 5.23 |
| 03:39 ET | 133 | 5.23 |
| 03:41 ET | 243 | 5.23 |
| 03:43 ET | 642 | 5.25 |
| 03:45 ET | 200 | 5.25 |
| 03:48 ET | 1920 | 5.25 |
| 03:50 ET | 3822 | 5.25 |
| 03:52 ET | 1000 | 5.26 |
| 03:54 ET | 2336 | 5.25 |
| 03:56 ET | 2829 | 5.25 |
| 03:57 ET | 2186 | 5.25 |
| 03:59 ET | 4319 | 5.25 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Design Therapeutics Inc | 276.8M | -5.0x | --- |
Artiva Biotherapeutics Inc | 277.3M | 0.0x | --- |
Monte Rosa Therapeutics Inc | 284.1M | -1.8x | --- |
Inovio Pharmaceuticals Inc | 283.7M | -2.0x | --- |
ATAI Life Sciences NV | 264.5M | -6.6x | --- |
Acrivon Therapeutics Inc | 258.4M | -3.1x | --- |
Company Information
Design Therapeutics, Inc. is a biotechnology company. It is engaged in the research and development of GeneTACT molecules, which are small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its Friedreich ataxia (FA) program is focused on the development of a disease-modifying treatment. Its DT-216 is developed to overcome the FXN transcription impairment that causes FA. DT-216 is in Phase I clinical trial. The Company is also engaged in developing DT-216 to enable higher exposure and chronic administration for treatment of FA, known as DT-216P2, which uses the same drug substance, DT-216. Its FECD program is focused on the development of a potentially disease-modifying medical treatment for FECD, DT-168, which is in Phase I clinical trial. Its HD program is focused on the development of a potentially disease-modifying treatment for HD.
Contact Information
- Headquarters
- 6005 Hidden Valley Road, Suite 110CARLSBAD, CA, United States 92011
- Phone
- 858-293-4900
- Fax
- 302-636-5454
Executives
- Chairman of the Board, President, Chief Executive Officer, Principal Financial Officer
- Pratik Shah
- Chief Operating Officer
- Sean Jeffries
- Chief Medical Officer
- Jae Kim
- Lead Independent Director
- Simeon George
- Independent Director
- Heather Berger
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $276.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 56.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.71 |
EPS | $-1.05 |
Book Value | $4.92 |
P/E Ratio | -5.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
